On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Omnix Medical Ltd's own share of each project, not the project's full budget.
- Horizon Europe€4.9M · 1 project
- Horizon 2020€2.4M · 1 project
Projects
2 EU-funded projects, newest first. Omnix Medical Ltd led 2 of them as coordinator. Each links to the official record.
- PEPTAMRCoordinator
Biomimetic antimicrobial peptide inspired by insects to combat multi-drug-resistant Acinetobacter baumannii
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€4.9Mtheir share - OMN6Coordinator
A novel class of antibiotics to combat Antimicrobial Resistance
Horizon 2020 · 2021–2023 · Project on CORDIS ↗
€2.4Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotic resistance
- antibiotics
- biomolecules
- drug discovery
- infectious diseases
- medicinal chemistry
- mortality
- multidrug resistance
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.